Kim G. Hankey

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Successful cancer immunotherapy is confounded by the magnitude of the tumor burden and the presence of immunoregulatory elements that suppress an immune response. To approach these issues, 26 patients with advanced treatment refractory cancer were enrolled in a safety/feasibility study wherein a conventional treatment modality, intensity modulated(More)
  • 1